These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21471439)

  • 1. Process evaluation of recruitment for a cancer screening trial in primary care.
    James AS; Daley CM; Engelman K; Greiner KA; Ellerbeck E
    Health Promot Pract; 2011 Sep; 12(5):696-703. PubMed ID: 21471439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparticipation in a population-based trial to increase colorectal cancer screening.
    Green BB; Bogart A; Chubak J; Vernon SW; Morales LS; Meenan RT; Laing SS; Fuller S; Ko C; Wang CY
    Am J Prev Med; 2012 Apr; 42(4):390-7. PubMed ID: 22424252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial.
    Lewis R; Todd R; Newton M; Jones RJ; Wilson C; Donovan JL; Bryan RT; Birtle A; Hall E;
    Trials; 2020 Jul; 21(1):629. PubMed ID: 32641097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.
    Hedges KNC; Borisov AS; Saukkonen JJ; Scott NA; Hecker EJ; Bozeman L; Dukes Hamilton C; Kerrigan A; Bessler P; Moreno-Martinez A; Arevalo B; Goldberg SV
    Clin Trials; 2020 Feb; 17(1):39-51. PubMed ID: 31690107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
    Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
    Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.
    Gohagan JK; Broski K; Gren LH; Fouad MN; Higgins D; Lappe K; Ogden S; Shambaugh V; Pinsky PF; O'Brien B; Yurgalevich S; Riley T; Wright P; Prorok PC
    Rev Recent Clin Trials; 2015; 10(3):187-93. PubMed ID: 26435288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for in-person recruitment: lessons learned from a New Jersey primary care research network (NJPCRN) study.
    Felsen CB; Shaw EK; Ferrante JM; Lacroix LJ; Crabtree BF
    J Am Board Fam Med; 2010; 23(4):523-33. PubMed ID: 20616295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening.
    Costanza ME; Luckmann R; Stoddard AM; White MJ; Stark JR; Avrunin JS; Rosal MC; Clemow L
    Cancer Detect Prev; 2007; 31(3):191-8. PubMed ID: 17646058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
    Walker JG; Macrae F; Winship I; Oberoi J; Saya S; Milton S; Bickerstaffe A; Dowty JG; De Abreu Lourenço R; Clark M; Galloway L; Fishman G; Walter FM; Flander L; Chondros P; Ait Ouakrim D; Pirotta M; Trevena L; Jenkins MA; Emery JD
    Trials; 2018 Jul; 19(1):397. PubMed ID: 30045764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
    Saya S; Boyd L; Chondros P; McNamara M; King M; Milton S; Lourenco RA; Clark M; Fishman G; Marker J; Ostroff C; Allman R; Walter FM; Buchanan D; Winship I; McIntosh J; Macrae F; Jenkins M; Emery J
    Trials; 2022 Sep; 23(1):810. PubMed ID: 36163034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving colorectal cancer screening rates in a managed care health plan: recruitment of provider organizations for a randomized effectiveness trial.
    Ganz PA; Farmer MM; Belman M; Malin JL; Bastani R; Kahn KL; Dietrich A; Fielding J
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):824-9. PubMed ID: 14504190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial.
    Simmons RG; Lee YC; Stroup AM; Edwards SL; Rogers A; Johnson C; Wiggins CL; Hill DA; Cress RD; Lowery J; Walters ST; Jasperson K; Higginbotham JC; Williams MS; Burt RW; Schwartz MD; Kinney AY
    Trials; 2013 Apr; 14():116. PubMed ID: 23782890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Pinsky PF; Ford M; Gamito E; Higgins D; Jenkins V; Lamerato L; Tenorio S; Marcus PM; Gohagan JK
    J Natl Med Assoc; 2008 Mar; 100(3):291-8. PubMed ID: 18390022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruiting Chinese Americans into cancer screening intervention trials: strategies and outcomes.
    Wang JH; Sheppard VB; Liang W; Ma GX; Maxwell AE
    Clin Trials; 2014 Apr; 11(2):167-77. PubMed ID: 24567288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.
    Simpson NK; Johnson CC; Ogden SL; Gamito E; Trocky N; McGuire C; Martin J; Barrow S; Lamerato L; Flickinger LM; Broski KG; Engelhard D; Hilke C; Bonk J; Gahagan B; Gren LH; Childs J; Lappe K; Fouad M; Thompson J; Sullivan D;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):356S-378S. PubMed ID: 11189688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and challenges in recruiting pregnant women to an infant obesity prevention programme delivered via telephone calls or text messages.
    Ekambareshwar M; Mihrshahi S; Wen LM; Taki S; Bennett G; Baur LA; Rissel C
    Trials; 2018 Sep; 19(1):494. PubMed ID: 30219067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized colorectal cancer screening intervention trial in the Iowa Research Network (IRENE): study recruitment methods and baseline results.
    Daly JM; Xu Y; Ely JW; Levy BT
    J Am Board Fam Med; 2012; 25(1):63-72. PubMed ID: 22218626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.